Literature DB >> 11676889

Analgesic/abortive overuse and misuse in chronic daily headache.

H C Diener1, Z Katasarva.   

Abstract

The frequent use (> 15 times/month) of medication for the treatment of acute migraine attacks may cause medication overuse headache. This kind of headache can be caused by the intake of combination analgesics, opioids, ergot alkaloids, and triptans. The delay between first intake and daily headache is shortest for triptans (1 to 2 years), longer for ergots (3 years), and longest for analgesics (5 years). Treatment includes drug withdrawal followed by structured acute therapy and initiation of migraine prophylactic treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11676889     DOI: 10.1007/s11916-001-0061-7

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  39 in total

1.  Kaplan Award 1998. Epidemiology of chronic daily headache in the general population.

Authors:  J Castillo; P Muñoz; V Guitera; J Pascual
Journal:  Headache       Date:  1999-03       Impact factor: 5.887

2.  Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects.

Authors:  G A PETERS; B T HORTON
Journal:  Proc Staff Meet Mayo Clin       Date:  1951-04-25

3.  Does analgesic abuse cause headaches de novo?

Authors:  F Lance; C Parkes; M Wilkinson
Journal:  Headache       Date:  1988-02       Impact factor: 5.887

4.  Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data.

Authors:  D Gaist
Journal:  Cephalalgia       Date:  1999-10       Impact factor: 6.292

5.  Prednisone as initial treatment of analgesic-induced daily headache.

Authors:  A V Krymchantowski; J S Barbosa
Journal:  Cephalalgia       Date:  2000-03       Impact factor: 6.292

6.  Drug induced refractory headache--clinical features and management.

Authors:  N T Mathew; R Kurman; F Perez
Journal:  Headache       Date:  1990-10       Impact factor: 5.887

7.  Repetitive intravenous dihydroergotamine as therapy for intractable migraine.

Authors:  N H Raskin
Journal:  Neurology       Date:  1986-07       Impact factor: 9.910

Review 8.  Caffeine physical dependence: a review of human and laboratory animal studies.

Authors:  R R Griffiths; P P Woodson
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

9.  Repetitive intravenous DHE in the treatment of refractory headache.

Authors:  S D Silberstein; E A Schulman; M M Hopkins
Journal:  Headache       Date:  1990-05       Impact factor: 5.887

10.  Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches.

Authors:  C Baumgartner; P Wessely; C Bingöl; J Maly; F Holzner
Journal:  Headache       Date:  1989-09       Impact factor: 5.887

View more
  5 in total

Review 1.  Psychiatric comorbidity in chronic daily headache: pathophysiology, etiology, and diagnosis.

Authors:  Vincenzo Guidetti; Federica Galli
Journal:  Curr Pain Headache Rep       Date:  2002-12

2.  Headache disorders: differentiating and managing the common subtypes.

Authors:  Fayyaz Ahmed
Journal:  Br J Pain       Date:  2012-08

3.  The pharmacological management of migraine, part 1: overview and abortive therapy.

Authors:  George Demaagd
Journal:  P T       Date:  2008-07

4.  Chronic daily headaches.

Authors:  Fayyaz Ahmed; Rajsrinivas Parthasarathy; Modar Khalil
Journal:  Ann Indian Acad Neurol       Date:  2012-08       Impact factor: 1.383

5.  Prophylaxis of migraine.

Authors:  Ivan Garza; Jerry W Swanson
Journal:  Neuropsychiatr Dis Treat       Date:  2006-09       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.